Literature DB >> 20828764

Aceruloplasminemia in a Japanese woman with a novel mutation of CP gene: clinical presentations and analysis of genetic and molecular pathogenesis.

Ayumi Hida1, Hisatomo Kowa, Atsushi Iwata, Masaki Tanaka, Shin Kwak, Shoji Tsuji.   

Abstract

We report a Japanese woman diagnosed as aceruloplasminemia showing characteristic symptoms. Mutational analysis of CP gene revealed a novel homozygous mutation in exon 18, resulting in prematurely truncated W1017X protein. In vitro study showed that W1017X mutant ceruloplasmin was deficient in endoplasmic reticulum to Golgi trafficking and was not secreted to medium. It has been reported that the presence of both the G (FLI/LI) GP domain and the 881th cysteine residue was sufficient for secretion. Thus, our report on this novel mutant indicates the previously unreported importance of carboxy-terminus residues in the secretion pathway.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20828764     DOI: 10.1016/j.jns.2010.08.019

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

Review 1.  Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Katharine Horback; Joseph Wong; Deepak Sharma; Amber Beserra; Srinivas Suda; Charumathi Anbalagan; Som Dev; Chinmay K Mukhopadhyay; Ajay Singh
Journal:  Antioxid Redox Signal       Date:  2013-08-15       Impact factor: 8.401

2.  Aceruloplasminemia with Abnormal Compound Heterozygous Mutations Developed Neurological Dysfunction during Phlebotomy Therapy.

Authors:  Maki Watanabe; Ken Ohyama; Masashi Suzuki; Yasunobu Nosaki; Takashi Hara; Katsushige Iwai; Satoshi Kono; Hiroaki Miyajima; Kenji Mokuno
Journal:  Intern Med       Date:  2018-04-27       Impact factor: 1.271

Review 3.  Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders.

Authors:  Vassilena Iankova; Ivan Karin; Thomas Klopstock; Susanne A Schneider
Journal:  Front Neurol       Date:  2021-04-15       Impact factor: 4.003

4.  A novel ceruloplasmin mutation identified in a Chinese patient and clinical spectrum of aceruloplasminemia patients.

Authors:  Wan-Qing Xu; Wang Ni; Rou-Min Wang; Yi Dong; Zhi-Ying Wu
Journal:  Metab Brain Dis       Date:  2021-08-04       Impact factor: 3.584

5.  Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports.

Authors:  Lena H P Vroegindeweij; Agnita J W Boon; J H Paul Wilson; Janneke G Langendonk
Journal:  Orphanet J Rare Dis       Date:  2020-04-25       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.